Related Experiment Video
Updated: Aug 6, 2026
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pneumonia caused by gram-negative bacilli: an overview
Abstract:
Colonization of the oropharynx by Pseudomonas aeruginosa and enteric gram-negative bacilli in acutely ill or debilitated patients, alcoholics, diabetics, and persons with chronic bronchitis may lead to pneumonia. Although gram staining of sputum may provide immediate etiologic clues, the diagnosis is proven only by isolation of the pathogen from blood or pleural fluid or by various invasive techniques since expectorated specimens from highly susceptible patients are often contaminated with aerobic gram-negative bacilli colonizing the oropharynx. However, restricting the definition of cases to those involving empyema or bacteremia results in an underestimation of incidence. Combination therapy with a beta-lactam antibiotic plus an aminoglycoside is commonly recommended for gram-negative bacillary pneumonia because (1) the patients involved are usually debilitated and immunocompromised; (2) mortality is high; and (3) the spectrum of antibacterial activity is increased, emergence of resistance may be retarded, and synergistic activity may result. For example, a third-generation cephem antibiotic plus an aminoglycoside can be used for initial treatment of community-acquired gram-negative bacillary pneumonia, and piperacillin or azlocillin plus amikacin can be used for initial treatment of nosocomial infection in which P. aeruginosa or some other antibiotic-resistant gram-negative bacillus is more likely to be involved.
Insights
Gram-negative bacilli colonization can cause pneumonia in vulnerable patients. Combination antibiotic therapy, like beta-lactam plus aminoglycoside, is recommended for effective treatment and to combat resistance.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Pulmonology
Background:
- Oropharyngeal colonization by Pseudomonas aeruginosa and enteric gram-negative bacilli poses a risk for pneumonia in susceptible individuals.
- Diagnosis of gram-negative bacillary pneumonia is challenging due to potential contamination of sputum specimens with colonizing bacteria.
- Current diagnostic methods may underestimate pneumonia incidence by focusing solely on invasive cases like empyema or bacteremia.
Purpose of the Study:
- To review the etiology, diagnosis, and treatment of gram-negative bacillary pneumonia.
- To highlight the importance of combination antibiotic therapy in managing this severe infection.
- To provide guidance on appropriate antibiotic choices for community-acquired versus nosocomial infections.
Main Methods:
- Literature review of studies on gram-negative bacillary pneumonia.
- Analysis of diagnostic challenges and limitations.
- Evaluation of current treatment guidelines and antibiotic efficacy.
Main Results:
- Gram-negative bacilli, including P. aeruginosa, are significant causes of pneumonia in debilitated and immunocompromised patients.
- Combination therapy (beta-lactam plus aminoglycoside) is the standard treatment due to high mortality, need for broad-spectrum coverage, and potential for synergy.
- Specific antibiotic regimens are recommended for community-acquired and nosocomial gram-negative bacillary pneumonia, considering likely pathogens and resistance patterns.
Conclusions:
- Prompt recognition and appropriate antibiotic treatment are crucial for improving outcomes in gram-negative bacillary pneumonia.
- Combination antibiotic therapy is essential for managing these infections effectively.
- Tailoring antibiotic selection based on the likely causative organism and local resistance patterns is vital for successful treatment.
More Related Videos
07:43A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
Published on: September 28, 2016
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:30Pneumonia III: Complications and Assessment
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:14Atypical Pneumonia
01:29Pneumonia I: Introduction